BioStar Capital
BioStar Ventures is a venture capital partnership that focuses on medical device technologies in cardiovascular and orthopaedic medicine.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed BioStar Capital Information
Geographic Data
Address: 206 Bridge Street
City: Charlevoix
State: MI
Zip: 49720
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
BioStar Ventures is a venture capital company that offers private equity investment services to firms in the medical device technology services industries. It was founded in 2003 by Louis Cannon and is based in Michigan.
Contact Phone:
+12314971286
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2011 | Ellipse Technologies | Series C | 17.6M |
| 6/2017 | Trice Medical | Series C | 0 |
| 5/2016 | TransMedics | Series F | 0 |
| 1/2015 | Trice Medical | Series B | 6.5M |
| 3/2014 | Domain Surgical | Series C | 35M |
| 12/2006 | AorTx | Venture Round | 5.8M |
| 4/2010 | Reverse Medical | Series B | 0 |
| 10/2011 | CV Ingenuity | Series B | 16M |
| 7/2022 | MMI | Series B | 0 |
| 1/2016 | V-Wave | Series B | 0 |
| 10/2022 | Amplitude Vascular Systems | Series A | 1.2M |
| 3/2018 | Corindus | Post-IPO Equity | 0 |
| 10/2009 | Embrella Cardiovascular | Series B | 1.6M |
| 2/2020 | Aria CV | Series B | 0 |
| 5/2012 | Kona Medical | Series C | 0 |
| 12/2014 | Conventus Orthopaedics | Series A | 0 |
| 1/2019 | Ablative Solutions | Series D | 0 |
| 4/2018 | V-Wave | Series C | 0 |
| 2/2019 | Corindus | Post-IPO Equity | 0 |
| 2/2017 | Corindus | Post-IPO Equity | 45M |
| 6/2012 | Ablative Solutions | Series A | 5.3M |
| 5/2009 | Revascular Therapeutics | Series B | 3M |
| 4/2005 | Avantis Medical Systems | Series A | 2.5M |
| 4/2008 | Corindus | Series B | 0 |
| 10/2006 | MiCardia Corporation | Series B | 9M |
| 7/2015 | Aria CV | Series A | 7.8M |
| 1/2023 | Amplitude Vascular Systems | Series B | 20M |
| 7/2014 | Trice Medical | Series B | 11.6M |
| 9/2015 | Kona Medical | Debt Financing | 10M |
| 10/2014 | VytronUS | Series B | 31.6M |
| 12/2012 | Kona Medical | Series C | 10M |
| 2/2014 | Ablative Solutions | Series B | 0 |
| 7/2016 | TransMedics | Private Equity Round | 0 |
| 2/2009 | SynergEyes | Series C | 0 |
| 11/2013 | Trice Orthopedics | Debt | 3M |
| 6/2022 | Ablative Solutions | Series D | 0 |
| 1/2019 | Trice Medical | Series C | 0 |
| 10/2017 | CathWorks | Series B | 0 |
| 9/2006 | Broncus Technologies | Series F | 0 |
| 6/2020 | Foldax | Series D | 0 |
| 8/2022 | REVA | Series B | 45M |
| 11/2006 | Avantis Medical Systems | Series B | 12M |
| 11/2013 | Trice Medical | Venture Round | 3M |
| 1/2013 | AngioSlide | Series D | 6.3M |
| 7/2022 | MMI | Series B | 0 |
| 6/2022 | Ablative Solutions | Series D | 0 |
| 6/2020 | Foldax | Series D | 0 |
| 2/2020 | Aria CV | Series B | 0 |
| 2/2019 | Corindus | Post-IPO Equity | 0 |
| 1/2019 | Trice Medical | Series C | 0 |
| 1/2019 | Ablative Solutions | Series D | 0 |
| 4/2018 | V-Wave | Series C | 0 |
| 3/2018 | Corindus | Post-IPO Equity | 0 |
| 10/2017 | CathWorks | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
